2020
DOI: 10.1016/j.ceramint.2020.01.086
|View full text |Cite
|
Sign up to set email alerts
|

Osteogenic silver oxide doped mesoporous bioactive glass for controlled release of doxorubicin against bone cancer cell line (MG-63): In vitro and in vivo cytotoxicity evaluation

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
21
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 42 publications
(23 citation statements)
references
References 35 publications
0
21
0
Order By: Relevance
“…75 The results demonstrated that these smart systems provided higher toxicity for cancer cells in vitro and showed a selective increase in tumor death in vivo. 15,[75][76][77][78][79][80][81][82][83][84][85][86] After entering the body, the drug goes through four stages, including absorption, release, F I G U R E 4 (A) Schematic of drug-loaded mesoporous bioactive glass (MBG) preparation. (B) The effect of MBGs on cancer cells and normal cells.…”
Section: Drug and Ion Deliverymentioning
confidence: 99%
See 1 more Smart Citation
“…75 The results demonstrated that these smart systems provided higher toxicity for cancer cells in vitro and showed a selective increase in tumor death in vivo. 15,[75][76][77][78][79][80][81][82][83][84][85][86] After entering the body, the drug goes through four stages, including absorption, release, F I G U R E 4 (A) Schematic of drug-loaded mesoporous bioactive glass (MBG) preparation. (B) The effect of MBGs on cancer cells and normal cells.…”
Section: Drug and Ion Deliverymentioning
confidence: 99%
“…Overall, 81% of IMT was released for 250 h at an acidic pH = 4.4, at 12.19 μg/ml of IMT-MBG, and significant inhibitory effects were observed on the viability of MG-63 osteosarcoma cancer cells. 74 It has been proven that hollow spheres of MBGs doped with different ions (Se, 77 Tb, 83 Ag, 84 Sm, 85 Ca 102,103 ) have a higher drug-loading capacity and more stable release than dopant-free BGs. Interaction between ions and drugs can synergistically enhance the anticancer effect and improve drug loading.…”
Section: Drug and Ion Deliverymentioning
confidence: 99%
“…[116] Moreover, drug loading concentrations affect the release profile of MBGs. [115,118] In addition to drug loading, ther-apeutic ions and trace elements also affect drug release profiles. Example (1); the addition of selenium (Se), europium (Eu), and terbium (Tb) to MBGs has been shown to decrease drug release kinetics.…”
Section: Chemotherapeutic Drug Deliverymentioning
confidence: 99%
“…A recent investigation developed silver oxide (Ag 2 O)-doped MBG nanoparticles for the controlled release of DOX and evaluated the anticancer activity in human bone tumor cells (MG-63). [118] It was proposed that Ag nanoparticles in combination with DOX could act as potential anticancer agents. Their cytotoxic mechanisms against tumor cells typically trigger oxidative stress, subsequent induction of mitochondrial damage, apoptosis, and DNA damage.…”
Section: Biomolecular Mechanisms Underlying Anticancer Effects Of Mbgsmentioning
confidence: 99%
“…These are usually synthesized by the evaporation-induced self-assembly (EISA) and sol-gel methods, which can obtain MBG with a uniform pore size and large surface area. In view of MBG's characterizations, it could be applied for the controlled releasing and stabilization of functional contents [15][16][17], as well as for enhancing bone formation by inducing hydroxyapatite (HA) crystallization on its surface [18][19][20]. In previous studies, silver-containing mesoporous bioactive glass (MBG-Ag) has been used as a biomaterial for combatting multidrug-resistant bacteria.…”
Section: Introductionmentioning
confidence: 99%